Enzo Biochem Inc (NYSE:ENZ)
$ 1.13 -0.04 (-3.42%) Market Cap: 57.88 Mil Enterprise Value: 4.83 Mil PE Ratio: 1.69 PB Ratio: 0.81 GF Score: 38/100

Q2 2021 Enzo Biochem Inc Earnings Call Transcript

Mar 15, 2021 / 08:30PM GMT
Release Date Price: $2.96 (+3.50%)
Operator

Greetings. Welcome to the Enzo Biochem Second Quarter 2021 Financial Results and Business Update. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, Jeremy Feffer, Investor Relations. Thank you. You may begin.

Jeremy Feffer

Thank you, Hilary, and good afternoon. Joining us today from the company are Barry Weiner, Co-Founder and President; and David Bench, Chief Financial Officer. A press release announcing the results and the update was issued this afternoon and is now available on the Enzo website.

I will now read the company's safe harbor statement. Except for historical information, the matters discussed in this news release may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the company and its management, including those related to cash flow, gross

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot